08 GB 44O7 0JGM

Powder Mixing Device

A London university have developed a micro-scale technology which can be used to improve the mixing of cohesive & non-cohesive pharmaceutical powders in large scale production processes. The chip has excellent potential as a powder mixing device and could be used in the manufacture of tablets, capsules and other products. The University are looking to licence the technology to partners in the pharmaceutical industry and other sectors where effective mixing of powders is required.

08 GB 40n6 0JI7

Cell penetrable poly-peptoids for topical drug delivery

Researchers in the University of Southampton (UK) have applied for patent protection for a class of cell penetrable polypeptide (poly-pseudo-lysine, PPL) which can act as a carrier for enabling cutaneous penetration of drugs. Such findings open the way to a new form of therapeutic treatment relying on PPL as a carrier for delivering therapeutic agents into skin. Commercial partners are sought for further testing with existing or novel therapeutics.

08 PT 65BN 0J2M

Novel peptide nucleic acid (PNA) probes for the rapid identification of pathogens

A Portuguese University has developed the application of novel peptide nucleic acid (PNA) probes as a high-tech molecular biology method to provide definitive results in less than 5 hours by fluorescence in situ hybridization (FISH). The methods have been developed for the detection of Salmonella spp., Staphylococcus epidermidis, Enterobacter sakazakii and Helicobacter pylori and can be easily adapted to other. Industrial partners are sought for licensing agreement and/or for further development.

08 DE 1592 0JDD

Innovative production and processing of ball and plan-convex-lenses.

A company from Lower Saxony produces and processes high innovative ball and plan-convex-lenses. They act as a supplier for micro-optics in the area of medical technology, telecommunication, research, automotive and laser industry.

Due to their innovative production and processing technology they produce high-precision lenses with a diameter of 0,8 mm till 16 mm adapted to specific needs. The company is searching for partners with special need of high precision lenses for a licence agreement.

08 GB 41n8 0JET

Product Integration Partners active in human and/or equine health

A UK company has developed a range of systems to monitor specific aspects of gait. One is a small self-contained data capture system for the analysis of motion in medical research, equine health & sports performance. Unlike competitive systems, it is wire-free and low cost. The company is seeking commercial partners interested in product integration/driving the system through to market.

08 FI 30h9 1N6Q

Myotilin, a new filament protein expressed in striated and cardiac muscle

A renowned Finnish research group has discovered and patented a new protein, myotilin. This protein or its fragments may be used in development of substances to control cell growth in various pathological conditions, especially diagnostics or therapeutics related to muscular dystrophy, as well as treatment of cancer or microbial infections. They wish to cooperate with biotech/pharmaceutical companies ready to sell and produce the antibodies and/or conducting R&D with myotilin protein.

08 ES 25E2 0J5K

Heart Rate detection without physical contact

A medium enterprise located in the Catalonia region (Spain) has patented a technology for detecting the Heart Rate of a person without any kind of physical contact. This technology, can be used for many applications, specially for burned patients and also for medical control of the heart of patients.

They are looking for partners to include the technology in their products. Other types of collaboration are welcome.

08 ES 25E2 0J5L

Bluetooth connection to mobile phone

A medical technology company located in Catalonia region (Spain) is developing a new product for medical control of some diseases. They need a provider that can help them to develop a connection from our device to a mobile phone.

08 DE 0855 0JI3

Improved test plant manufacturing for laboratory and pilot membrane installations

A small German company, specialised in the design and manufacturing of laboratory and pilot equipment for membrane technology applications, is looking for end-users from research and industry for licensing or commercial agreements with technical assistance. The plants are characterised by a higher degree of automation and more compact construction than conventional installatons. Applications include ultra-, micro- and nanofiltration as well as reverse osmosis.

08 CY 0641 27IS

MRI guided High Intensity Focused Ultrasound (HIFU) System for Destroying Tumors and Clots in the Brain.

A Cypriot start up is offering a unique MRI quided High Intensity Focused Ultrasound (HIFU) system intended to destroy tumors and clots in the brain using thermal and mechanical properties of ultrasound respectively. The company has designed and tested in animals a prototype 3-d robot and now is in the process to commercialize the system. The SME is seeking for manufacturers of medical carts for further development of the system. Financial resources are also welcome.

08 DE 1486 1N6G

Substance for reduction of UV-induced DNA damage

A Bavarian technology transfer centre representing a renowned German university hospital well-known for its dermatology department has found a substance that is capable of inducing the NER system (nucleotide excision repair), which reduces DNA damage. Accordingly, the substance reduces the UV-induced programmed cell death that is caused by DNA damage. The invention can be applied in the cosmetic sector, particularly in the range of sunscreen and skin ageing. They are looking for a licencee.

08 SE 67BY 0J24

Technical solution to avoid legionella bacteria in water supply systems

A Swedish SME company offers partners to produce and/or sell a patented tap water system and develop mixers, under license, which protects people from legionella infection.

08 IL 80EP 27F3

Automatic preparation and dispensing of liquid medication at the patient bed side

An Israeli SME has developed an automated system for computer controlled preparation and delivery of liquid medications at the patient’s bedside in critical care units at hospitals. No similar automated systems exist. The system eases the work of the medical team, saves time and reduces probability of medication errors, particularly in situations of working under stress, thus increasing patient safety. Partners are sought for validation and joint ventures.

08 IL 80EP 0JGY

Deep pressure calming vest for special populations

An Israeli SME has developed a device for performing deep pressure therapy to produce a calming effect, especially in such special populations as people with autism or ADHD.  The device is in the form of a vest which delivers deep pressure to the body through the use of inflatable cells.  Biometric sensors control the operation of the device in automatic mode.  Pressure is varied to prevent habituation.  The SME seeks partners for further development, sales and distribution.

08 DE 0957 0JG0

Technology to create 3-D sculptures from ultrasonic imaging data

A Saxon company developed a technology which allows to create 3-D sculptures of from ultrasonic imaging data, e.g. data from the ultrasound scans made by a gynaecologist is transformed into an individual sculpture of an unborn baby. The technology can be adapted for various kind of building model prototypes. Technical cooperation and commercial agreements with technical assistance are sought.

08 DE 0957 0JGL

CO2 breath test instrument for simple and fast diagnostic and monitoring

A Saxon company developed a CO2 breath test instrument as a highly sensitive analysis instrument for the determination of the ratio of the stable isotopes 13C and 12C in the CO2 of respiratory gases. The application field of the device are all diagnosis techniques in which tracer substances marked with the 13C stable isotope are catabolised and finally expelled through respiration.

The company looks for partners in medicine, animal nutrition, for commercial agreements with technical assistance.

08 SE 67CL 27GH

Production technology for a controlled release tablet containing viable probiotic substances or enzymes and vaccines.

A Swedish SME has developed a patented technology for production of tablets with low compression, allowing production of tablets containing viable probiotic cultures, proteins, enzymes or vaccines with controlled release characteristics. The company is looking for industrial partners interested in licensing the technology or for development of new types of pro- and prebiotics.